A compound identified at Vanderbilt has therapeutic potential in protecting the kidney filter barrier.

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.

Targeting the enzyme FosB could make antibiotic-resistant staph bacteria sensitive to the antibiotic fosfomycin.

The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development.

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.

Vanderbilt investigators report new insights to the workings of calprotectin, an immune system protein that “starves” bacterial pathogens of the metal nutrients they require.